Map Explore Ask

More ▾

Track recordWhat has been tried, and how it went Read with AIAsk one trial or paper, answered in its own words CompareTwo to ten studies side by side MatchLabs that should be talking DigestWhat is new today FundingWhere the money is, and is not

Search/

Sources: ClinicalTrials.gov · Europe PMC · NIH RePORTER · OpenAlexContracts 0.3.3Research and education only, not treatment advice

what is known about trial:nct:NCT07436741

Question

Understood asRecord NCT07436741View getStudy → table

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer NCT07436741 ↗ Outcome: Ongoing

Computed from the knowledge API (getStudy); every record links to its source.

Read it with AI